St. John' wort (Hypericum perforatum L.) - Multicompound preparations versus single substances;Johanniskraut (Hypericum perforatum L.) - Vielstoffgemische kontra phytogene einzelstoffe

Forschende Komplementarmedizin und Klassische Naturheilkunde

Volumn 10, Issue SUPPL. 1, 2003, Pages 28-32

  Reichling, Jurgen ^a   Hostanska, K ^b   Saller, R ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Antidepressant effect; Growth inhibitory activity; St. John's wort

Indexed keywords

FLAVANOID; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; PHLOROGLUCINOL; PROCYANIDIN;

AQUEOUS SOLUTION; CANCER CELL; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; GROWTH INHIBITION; HUMAN; HYPERICUM PERFORATUM;

ANTIDEPRESSIVE AGENTS; DEPRESSION; DRUG SYNERGISM; HUMANS; HYPERICUM; PHYTOTHERAPY; PLANT EXTRACTS; TREATMENT OUTCOME;

EID: 0038542170     PISSN: 14247364     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071689     Document Type: Conference Paper

References (10)

1. Czygan FC: Kulturgeschichte und Mystik des Johanniskrautextraktes. Z Phytother 1993;14:276-281.
2. Hostanska K, Reichling J, Bommer S, Weber M, Saller R: Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro. Pharmazie 2002;57:323-331.
3. Hostanska K, Reichling J, Bommer S, Weber M, Saller R: Hyperforin a constituent of St. John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically excerts cytotoxicity torward human malignant cell lines. Eur J Pharm Biopharm 2003 (zur Publikation angenommen).
4. Linde K, Ramirez G, Mulrow CD, Pauls M, Weidenhammer W, Melchart D: St. John's Wort for depression - an overview and meta-analysis of randomized clinical trials. BMJ 1996;313:253-258.
5. Wurglics M, Westerhoff K, Holoubek G, Schubert-Zsilavecz M, Müller WE: Aktuelle Johanniskrautforschung. Dtsch Apot Z 2002;142:1153-1174.
6. Winterhoff H, Butterweck V, Nahrstedt A, Gumbinger HG, Schulz V, Erping S, Boßhammer F, Wieligmann A: Pharmakologische Untersuchungen zur antidepressiven Wirkung von Hypericum perforatum L; in Loew D, Rietbrock N (Hrsg): Phytopharmaka in Forschung und klinischer Anwendung. Darmstadt, Steinkopff, 1995, pp 39-56.
7. Chatterjee SS, Bhattacharya M, Wonnemann M, Singer A, Müller WE: Hyperforin as a possible antidepressant component of Hypericum extracts. Life Sci 1998;63:499-510.
8. Butterweck V, Petereit F, Winterhoff H, Nahrstedt A: Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test. Planta Med 1998;64:291-294.
9. Nöldner M, Schötz K: Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Med 2002;68:577-580.
10. Wagner H: Neue Entwicklungen und Ergebnisse der phytomedizinischen Forschung. Z Phytother 2002;164-168.